NASSIM USMAN

Insider Reports History

Signature
/s/ Ruoyu Chen, as attorney-in-fact for Nassim Usman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by NASSIM USMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. Director Common Stock 1,636 $19,639 $12.00 28 Jun 2024 Direct
GYRE THERAPEUTICS, INC. Director Common Stock 563 $6,758 $12.00 28 Jun 2024 By The Usman Family Trust
GYRE THERAPEUTICS, INC. Director Common Stock 77 $924 $12.00 28 Jun 2024 By Nassim Usman IRA
GYRE THERAPEUTICS, INC. Director Stock Option (Right to Buy) 278,200 28 Jun 2024 Direct
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 31 Aug 2023 By Nassim Usman IRA
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 31 Aug 2023 By The Usman Family Trust
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 31 Aug 2023 Direct

Insider Reports Filed by NASSIM USMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GYRE GYRE THERAPEUTICS, INC. 28 Jun 2024 3 -$17,515 4 Director 01 Jul 2024, 18:00
GYRE GYRE THERAPEUTICS, INC. 01 May 2024 5 -$143,977 4 Director 02 May 2024, 18:19
GYRE GYRE THERAPEUTICS, INC. 01 Apr 2024 3 -$184,400 4 Director 03 Apr 2024, 16:01
GYRE GYRE THERAPEUTICS, INC. 15 Mar 2024 3 -$206,600 4 Director 19 Mar 2024, 16:47
GYRE GYRE THERAPEUTICS, INC. 31 Oct 2023 2 $0 4 Director 01 Nov 2023, 06:15
GYRE CATALYST BIOSCIENCES, INC. 31 Aug 2023 3 $0 4 President & CEO, Director 01 Sep 2023, 16:07
GYRE CATALYST BIOSCIENCES, INC. 09 Aug 2022 1 +$1,528 4 President & CEO, Director 10 Aug 2022, 17:19
GYRE CATALYST BIOSCIENCES, INC. 09 Feb 2022 1 +$1,495 4 President & CEO, Director 16 Feb 2022, 19:13
GYRE CATALYST BIOSCIENCES, INC. 09 Aug 2021 1 +$3,139 4 President & CEO, Director 11 Aug 2021, 09:15